Manufacturer
Novartis NDC Codes
Finished products listed with the FDA under labeler names that contain “Novartis”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Jadenudeferasirox | Deferasirox 90 mg/1 | GranuleOral | Novartis Pharmaceuticals Corporation | 0078-0727 |
| Kesimptaofatumumab | Ofatumumab 20 mg/.4mL | Injection, SolutionSubcutaneous | Novartis Pharmaceuticals Corporation | 0078-1007 |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0860 |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0867 |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0874 |
| Kymriahtisagenlecleucel | Tisagenlecleucel 2000000 1/1 | Injection, SuspensionIntravenous | Novartis Pharmaceuticals Corporation | 0078-0846 |
| Kymriahtisagenlecleucel | Tisagenlecleucel 60000000 1/1 | Injection, SuspensionIntravenous | Novartis Pharmaceuticals Corporation | 0078-0958 |
| Lampreneclofazimine | Clofazimine 50 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-1049 |
| Leqvioinclisiran | Inclisiran sodium 284 mg/1.5mL | Injection, SolutionSubcutaneous | Novartis Pharmaceuticals Corporation | 0078-1000 |
| Locametzkit for the preparation of gallium ga 68 gozetotide | Gozetotide 25 ug/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Novartis Pharmaceuticals Corporation | 0078-1224 |
| Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasone | Neomycin sulfate 3.5 mg/g + 2 more ingredients | OintmentOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0771 |
| Mayzentsiponimod | Siponimod .25 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0979 |
| Mayzentsiponimod | Siponimod 2 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0986 |
| Mayzentsiponimod | Siponimod 1 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1014 |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide .5 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1105 |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide 2 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1112 |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide .05 mg/mL | Powder, For solutionOral | Novartis Pharmaceuticals Corporation | 0078-1161 |
| Myforticmycophenolic acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | Novartis Pharmaceuticals Corporation | 0078-0385 |
| Myforticmycophenolic acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | Novartis Pharmaceuticals Corporation | 0078-0386 |
| Neoralcyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-0246 |
| Neoralcyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-0248 |
| Neoralcyclosporine | Cyclosporine 100 mg/mL | SolutionOral | Novartis Pharmaceuticals Corporation | 0078-0274 |
| Piqrayalpelisib | Alpelisib 200 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0701 |
| Piqrayalpelisib | Alpelisib 150 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0708 |
| Piqrayalpelisib | — | Kit | Novartis Pharmaceuticals Corporation | 0078-0715 |